Controversies in the preoperative radiotherapeutic management of resectable esophageal cancer

[1]  M. Hall,et al.  Improving the therapeutic index for nonoperable esophageal cancer patients with modern radiation technologies , 2018, Applied Radiation Oncology.

[2]  E. Yorke,et al.  Impact of lung and heart dose on survival after radiotherapy for esophageal cancer. , 2018 .

[3]  Fei Jia,et al.  Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer , 2017, Medicine.

[4]  S. Swisher,et al.  Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study , 2017, Advances in radiation oncology.

[5]  K. Gurusamy,et al.  Non-surgical versus surgical treatment for oesophageal cancer. , 2016, The Cochrane database of systematic reviews.

[6]  Daniel T Chang,et al.  Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. , 2015, International journal of radiation oncology, biology, physics.

[7]  R. Shridhar,et al.  Radiation therapy and esophageal cancer. , 2013, Cancer control : journal of the Moffitt Cancer Center.

[8]  P. Thall,et al.  Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. , 2012, International journal of radiation oncology, biology, physics.

[9]  R. Mohan,et al.  Proton beam therapy and concurrent chemotherapy for esophageal cancer. , 2012, International journal of radiation oncology, biology, physics.

[10]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[11]  G. Starkschall,et al.  Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors. , 2010, International journal of radiation oncology, biology, physics.

[12]  L. Collette,et al.  EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Mohan,et al.  Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. , 2008, International journal of radiation oncology, biology, physics.

[15]  P. Maingon,et al.  Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Radhe Mohan,et al.  Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Yi-Jen Chen,et al.  Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. , 2007, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[18]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Val Gebski,et al.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.

[20]  Helen H Liu,et al.  Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. , 2006, International journal of radiation oncology, biology, physics.

[21]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[22]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Mohan,et al.  Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. , 2003, International journal of radiation oncology, biology, physics.

[24]  R. Ginsberg,et al.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Cooper,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.

[27]  J. Bosset,et al.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.

[28]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[29]  J. Cooper,et al.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. , 1992, The New England journal of medicine.

[30]  R. Earlam,et al.  Oesophageal squamous cell carcinoma: I. A critical review of surgery , 1980, The British journal of surgery.

[31]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.